Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2002-01-30
2009-08-18
Epps-Smith, Janet L (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093700, C424S458000, C514S04400A
Reexamination Certificate
active
07575743
ABSTRACT:
Compositions and methods are provided for treatment of cartilage defects in animals and humans. The compositions of the invention include synovial tissue, synovial cells and matrices containing synovial (or cambium) tissue or cells for use in filling a cartilage defect. The matrix and synovial tissue or cell preparations may also contain a proliferation agent, transforming factor or other active agents to promote healing. A controlled-release delivery system may be used to administer the transforming factor. The compositions of the invention also include a synovial covering membrane or devitalized fascial sheet for covering the cartilage defect. The methods of this invention are those in which a minimally invasive surgical intervention is performed to remove a small portion of synovial membrane from a joint. Portions of the synovial membrane, or cells expanded in vitro, are implanted alone or within a matrix, into the defect site, where they produce new cartilage tissue and repair the defect. Alternatively, partially transformed synovial-derived tissue may be formed in situ and implanted into the defect site.
REFERENCES:
patent: 4378224 (1983-03-01), Nimni et al.
patent: 4506673 (1985-03-01), Bonnell
patent: 4846835 (1989-07-01), Grande
patent: 5206023 (1993-04-01), Hunziker
patent: 5270300 (1993-12-01), Hunziker
patent: 5368858 (1994-11-01), Hunziker
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5811094 (1998-09-01), Caplan et al.
patent: 5853746 (1998-12-01), Hunziker
patent: 6027743 (2000-02-01), Khouri et al.
patent: 6110482 (2000-08-01), Khouri et al.
patent: 6254635 (2001-07-01), Schroeder et al.
patent: 6413511 (2002-07-01), Glorioso et al.
patent: 6530956 (2003-03-01), Mansmann
patent: 2002/0039567 (2002-04-01), Wallimann et al.
patent: 2002/0098168 (2002-07-01), Glorioso et al.
patent: 0267015 (1992-09-01), None
patent: WO 00/48550 (2000-08-01), None
Archer, “Skeletal Development and Osteoarthritis,”Ann. Rheum. Dis., 53, pp. 624-630 (1994).
Beaupre et al., “Knee Menisci,”Clin. Orthop. Rel. Res., 208, pp. 72-75 (1986).
Buckwalter et al., “Articular Cartilage: Coposition, Structure, Response to Injury, and Methods of Facilitating Repair,”Articular Cartilage and Knee Joint Function: Basic Science and Arthroscopy(New York: Raven Press, 1990) pp. 19-56.
Buckwalter et al., “Articular Cartilage: Injury and Repair,”Injury and Repair of the Musculoskeletal Soft Tissues(Park Ridge, III.: American Academy of Orthopaedic Surgeons Symposium, 1987) pp. 465-482.
Canalis et al., “Effects of Basic Fibroblast Growth Factor on Bone Formation in Vitro,”J. Clin. Invest., 81, pp. 1572-1577 (1988).
Caplan et al., “Principles of Cartilage Repair and Regeneration,”Clin. Orthop., 342, pp. 254-269 (1997).
Derynck et al., “Human Transforming Growth Factor-β Complementary DNA Sequence and Expression in Normal and Transformed Cells,”Nature, 316, pp. 701-705 (1985).
Dickson et al., “Assay of Mitogen-Induced Effects on Cellular Incorporation of Precursors for Scavengers, de novo, and Net DNA Synthesis,”Methods Enzymol., 146A, pp. 329-340 (1987).
Gibble et al., “Fibrin Glue: the Perfect Operative Sealant?,”Transfusion, 30(8), pp. 741-747 (1990).
Gimenez-Gallego et al., Human Brain-Derived Acidic and Basic Fibroblast Growth Factors: Amino Terminal Sequences and Specific Mitogenic Activities,Biochem. Biophys. Res. Commun., 135(2), pp. 541-548 (1986).
Hunziker et al., Removal of Proteoglycans from the Surface of Defects in Articular Cartilage Transiently Enhances Coverage by Repair Cells, J. Bone Joint Surg., 80(1), pp. 144-150 (1998).
Ichinose et al., “Structure of Transglutaminases,”J. Biol. Chem., 265(23), pp. 13411-13414 (1990).
Ingber et al., “Synthetic Analogues of Fumagillin that Inhibit Angiogenesis and Suppress Tumour Growth,”Nature, 348(6), pp. 555-557 (1990).
Iwamoto et al., “Actions of Hedgehod Proteins on Skeletal Cells,”Crit. Rev. Oral Biol. Med., 10(4), pp. 477-486 (1999).
Iwata et al., “Bone Morphogenetic Protein-Induced Muscle- and Synovium-Derived Cartilage Differentiation In Vivo,”Clin. Orthop., 296, pp. 295-300 (1993).
Jurgensen et al., “A New Biological Glue for Cartilage-Cartilage Interfaces: Tissue-Transglutaminase,”J. Bone Joint Surg. Am., 79(2), pp. 185-193 (1997).
Knutson et al., “Arthrodesis for Failed Knee Arthroplasty,”J. Bone and Joint Surg., 67B(1), pp. 47-52 (1985).
Knutson et al., “Arthrodesis After Failed Knee Arthroplasty,”Clin. Orthop., 191, pp. 202-211 (1984).
Kolettas et al., “Chondrocyte Phenotype and Cell Survival are Regulated by Culture Conditions and by Specific Cytokines through the Expressino of Sox-9 Transcription Factor,”Rheumatology, 40, pp. 1146-1156 (2001).
Kuettner, K.E., “Biochemistry of Articular Cartilage in Health and Disease,”Clin. Biochem., 25, pp. 155-163 (1992).
Lohmander et al., “Intra-Articular Hyaluronan Injectons in the Treatment of Osteoarthritis of the Knee: a Randomised, Double Blind, Placebo Controlled Multicentre Trial,”Ann. Rheum. Dis., 55(7), pp. 424-431 (1996).
Lorand et al, “Transglutaminase,”Mol. Cell. Biochem., 58, pp. 9-35 (1984).
Luyten, “Cartilage-Derived Morphogenic Proteins,”Acta Orthop. Scand. Suppl., 266, pp. 51-54 (1995).
Majumdar, et al., “BMP-2 and BMP-9 Promote Chondrogenic Differentiation of Human Multipotential Mesenchymal Cells and Overcome the Inhibitory Effect of IL-1,”J. Cell. Physiol., 189, pp. 275-284 (2001).
Maquet, “The Biomechanics of the Knee and Surgical Possibilities of Healting Osteoarthritic Knee Joints,”Clin. Orthop., 146, pp. 102-110 (1980).
Mitchell et al., “The Deleterious Effects of Drying on Articular Cartilage,”J. Bone Joint Surg., 71A(1), pp. 89-95 (1989).
Moses, “A Cartilage-Derived Inhibitor of Neovascularization and Metalloproteinases,”Clinical&Exptl. Rheumatology, 11(8), pp. 567-569 (1993).
Moses, M.A. et al., “Identification of an Inhibitor of Neovascularization from Cartilage,”Science, 248, pp. 1408-1410 (1990).
Moses et al., “Isolation and Characterization of an Inhibitor of Neovacularization from Scapular Chondrocytes,” J. Cell Bio., 119(2), pp. 475-482 (1992).
Peacock et al., “A Novel Angiogenesis Inhibitor Suppresses Rat Adjuvant Arthritis,”Cellular Immunology, 160, pp. 178-184 (1995).
Rizzino, “Transforming Growth Factor-β: Multiple Effects on Cell Differentiation and Extracellular Matrices,”Dev. Biol., 130(2), pp. 411-422 (1988).
Rizzino, “Soft Agar Growth Assays for Transforming Growth Factors and Mitogenic Peptides,”Methods Enzymol., 146A, pp. 341-352 (1987).
Roberts et al., “Purification of Type β Transforming Growth Factors From Nonneoplastic Tissues,”Methods for Preparation of Media, Supplements, and Substrata for Serum-Free Animal Cell Culture, pp. 181-194 (1984).
Roberts et al., “The Transforming Growth Factor-βs,”Handbook of Experimental Pharmacology, 95(1), pp. 419-472 (1990).
Rodel et al., “Primary Cultivation of Human Synovial Cells from Nonrheumatic Synovial Tissue and Fluid,”Exp. Toxicol. Pathol., 48, pp. 243-247 (1996).
Ruoslathi et al., “Arg-Gly-Asp: A Versatile Cell Recognition Signal,”Cell, 44, pp. 517-518 (1986).
Seyedin et al., “Cartilage-Inducing Factor-B is a Unique Protein Structurally and Functionally Related to Transforming Growth Factor-β,”J. Biol. Chem., 262(5), pp. 1946-1949 (1987).
Seyedin et al., “Cartilage-Inducing Factor-A,”J. Biol. Chem., 261(13), pp. 5693-5695 (1986).
Seyedin et al., “Modulation of Chondroblast Phenotype by Transforming Growth Factor-Beta,”Pathol. Immunolpatol. Res., 7, pp. 38-42 (1988).
Seyedin et al., “Purification and Characterization of Two Cartilage-Inducing Factors from Bov
Epps-Smith Janet L
Orthogene, Inc.
Ropes & Gray LLP
LandOfFree
Compositions and methods for the treatment and repair of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment and repair of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment and repair of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061940